This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Scripps Research Institute. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Gennadii Grabovyi: Innovator in Coronavirus Treatment
Introduction
Gennadii Grabovyi is a notable inventor based in La Jolla, California. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of treatments for viral infections.
Latest Patents
Gennadii Grabovyi holds a patent for "Protease inhibitors for treatment of coronavirus infections." This patent includes compounds that are potent inhibitors of the main protease of severe acute respiratory syndrome Coronavirus-2 (SARS-CoV-2). The compounds are designed to be useful in treating or preventing COVID-19 in affected subjects.
Career Highlights
Gennadii is affiliated with The Scripps Research Institute, where he conducts his research and development work. His innovative approach to drug design has positioned him as a key figure in the fight against viral infections.
Collaborations
Some of his notable coworkers include Arnab Kumar Chatterjee and Jian Jeffrey Chen. Their collaborative efforts contribute to advancing research in the field of virology and therapeutics.
Conclusion
Gennadii Grabovyi's work exemplifies the critical role of inventors in addressing global health challenges. His contributions to the development of protease inhibitors highlight the importance of innovation in the pharmaceutical industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile